• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于发现新型抗菌化合物的药物重新利用的基于树的定量构效关系模型

Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds Against .

作者信息

Suay-Garcia Beatriz, Falcó Antonio, Bueso-Bordils J Ignacio, Anton-Fos Gerardo M, Pérez-Gracia M Teresa, Alemán-López Pedro A

机构信息

Departamento de Matemáticas, Física y Ciencias Tecnológicas, Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.

Departamento de Farmacia Universidad Cardenal Herrera-CEU, CEU Universities, Alfara del Patriarca, 46115 Valencia, Spain.

出版信息

Pharmaceuticals (Basel). 2020 Nov 28;13(12):431. doi: 10.3390/ph13120431.

DOI:10.3390/ph13120431
PMID:33260726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7760995/
Abstract

Drug repurposing appears as an increasing popular tool in the search of new treatment options against bacteria. In this paper, a tree-based classification method using Linear Discriminant Analysis (LDA) and discrete indexes was used to create a QSAR (Quantitative Structure-Activity Relationship) model to predict antibacterial activity against Escherichia coli. The model consists on a hierarchical decision tree in which a discrete index is used to divide compounds into groups according to their values for said index in order to construct probability spaces. The second step consists in the calculation of a discriminant function which determines the prediction of the model. The model was used to screen the DrugBank database, identifying 134 drugs as possible antibacterial candidates. Out of these 134 drugs, 8 were antibacterial drugs, 67 were drugs approved for different pathologies and 55 were drugs in experimental stages. This methodology has proven to be a viable alternative to the traditional methods used to obtain prediction models based on LDA and its application provides interesting new drug candidates to be studied as repurposed antibacterial treatments. Furthermore, the topological indexes and have proven to have the ability to group active compounds effectively, which suggests a close relationship between them and the antibacterial activity of compounds against .

摘要

药物重新利用似乎是寻找新型抗细菌治疗方案中越来越受欢迎的工具。在本文中,一种使用线性判别分析(LDA)和离散指标的基于树的分类方法被用于创建一个定量构效关系(QSAR)模型,以预测对大肠杆菌的抗菌活性。该模型由一个层次决策树组成,其中使用一个离散指标根据化合物在该指标上的值将其分为不同组,以便构建概率空间。第二步是计算一个判别函数,该函数决定模型的预测。该模型被用于筛选药物银行数据库,识别出134种药物作为可能的抗菌候选药物。在这134种药物中,8种是抗菌药物,67种是已被批准用于不同病症的药物,55种是处于实验阶段的药物。这种方法已被证明是用于获得基于LDA的预测模型的传统方法的可行替代方案,其应用提供了有趣的新型候选药物,可作为重新利用的抗菌治疗方法进行研究。此外,拓扑指标 和 已被证明有能力有效地对活性化合物进行分组,这表明它们与化合物对 的抗菌活性之间存在密切关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/418bf53fcfd4/pharmaceuticals-13-00431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/64354e840ca8/pharmaceuticals-13-00431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/20221e8eec97/pharmaceuticals-13-00431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/418bf53fcfd4/pharmaceuticals-13-00431-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/64354e840ca8/pharmaceuticals-13-00431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/20221e8eec97/pharmaceuticals-13-00431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8caa/7760995/418bf53fcfd4/pharmaceuticals-13-00431-g003.jpg

相似文献

1
Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds Against .用于发现新型抗菌化合物的药物重新利用的基于树的定量构效关系模型
Pharmaceuticals (Basel). 2020 Nov 28;13(12):431. doi: 10.3390/ph13120431.
2
Topological index as a factor determining the antibacterial activity of quinolones against .拓扑指数作为决定喹诺酮类药物对 抗菌活性的因素。
Future Med Chem. 2019 Sep;11(17):2255-2262. doi: 10.4155/fmc-2019-0073.
3
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.抗菌剂的统一定量构效关系方法。4. 抗病毒药物 - 药物复合网络巨型组件的多靶点定量构效关系建模与比较多距离研究。
Bioorg Med Chem. 2009 Jan 15;17(2):569-75. doi: 10.1016/j.bmc.2008.11.075. Epub 2008 Dec 6.
4
Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.抗菌剂的统一定量构效关系方法。第3部分:用于抗原生动物化合物的输入编码预测、结构反向投影和复杂网络聚类的首个多任务定量构效关系模型。
Bioorg Med Chem. 2008 Jun 1;16(11):5871-80. doi: 10.1016/j.bmc.2008.04.068. Epub 2008 Apr 29.
5
Topological Model for the Search of New Antibacterial Drugs. 158 Theoretical Candidates.新型抗菌药物研发的拓扑模型。158个理论候选药物。
Curr Comput Aided Drug Des. 2015;11(4):336-45. doi: 10.2174/1573409912666151126214242.
6
Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance.抗菌剂的统一定量构效关系方法。第2部分:预测对90多种不同物种的活性以遏制抗菌药物耐药性。
Bioorg Med Chem. 2007 Jan 15;15(2):897-902. doi: 10.1016/j.bmc.2006.10.039. Epub 2006 Oct 21.
7
Antiprotozoan lead discovery by aligning dry and wet screening: prediction, synthesis, and biological assay of novel quinoxalinones.通过整合虚拟筛选和湿实验筛选发现抗原生动物药物先导物:新型喹喔啉酮的预测、合成及生物学测定
Bioorg Med Chem. 2014 Mar 1;22(5):1568-85. doi: 10.1016/j.bmc.2014.01.036. Epub 2014 Jan 31.
8
Discrimination and selection of new potential antibacterial compounds using simple topological descriptors.
J Mol Graph Model. 2003 Mar;21(5):375-90. doi: 10.1016/s1093-3263(02)00184-5.
9
Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.多靶标光谱矩用于定量构效关系和抗菌药物复杂网络研究。
Eur J Med Chem. 2009 Nov;44(11):4516-21. doi: 10.1016/j.ejmech.2009.06.018. Epub 2009 Jun 24.
10
3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.3D MI-DRAGON:用于构建美国食品和药物管理局药物-靶标网络的新模型,以及针对 AChE 的 rasagiline 衍生物抑制剂的理论-实验研究。
Curr Top Med Chem. 2012;12(16):1843-65.

引用本文的文献

1
Pharmacokinetic Equations Applied to Obtain New Topological Models in the Search of Antibacterial Compounds.应用药代动力学方程以获取用于寻找抗菌化合物的新拓扑模型。
Pharmaceuticals (Basel). 2025 Jun 10;18(6):865. doi: 10.3390/ph18060865.
2
Drug repurposing targeting COVID-19 3CL protease using molecular docking and machine learning regression approaches.使用分子对接和机器学习回归方法针对新冠病毒3CL蛋白酶进行药物重新利用研究
Sci Rep. 2025 May 28;15(1):18722. doi: 10.1038/s41598-025-02773-7.
3
Overview of Computational Toxicology Methods Applied in Drug and Green Chemical Discovery.

本文引用的文献

1
Molecular Topology for the Discovery of New Broad-Spectrum Antibacterial Drugs.分子拓扑学在新型广谱抗菌药物发现中的应用。
Biomolecules. 2020 Sep 19;10(9):1343. doi: 10.3390/biom10091343.
2
QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models.QSAR-Co:用于开发稳健的多任务或多目标分类定量构效关系模型的开源软件。
J Chem Inf Model. 2019 Jun 24;59(6):2538-2544. doi: 10.1021/acs.jcim.9b00295. Epub 2019 May 24.
3
Beyond model interpretability using LDA and decision trees for α-amylase and α-glucosidase inhibitor classification studies.
应用于药物和绿色化学发现的计算毒理学方法概述。
J Xenobiot. 2024 Dec 4;14(4):1901-1918. doi: 10.3390/jox14040101.
4
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade.用于结核病治疗的潜在重新利用药物候选物:十多年来已确定药物的进展与更新
ACS Omega. 2023 May 10;8(20):17362-17380. doi: 10.1021/acsomega.2c05511. eCollection 2023 May 23.
5
Machine Learning in Antibacterial Drug Design.抗菌药物设计中的机器学习
Front Pharmacol. 2022 May 3;13:864412. doi: 10.3389/fphar.2022.864412. eCollection 2022.
6
New Pharmacokinetic and Microbiological Prediction Equations to Be Used as Models for the Search of Antibacterial Drugs.用作抗菌药物搜索模型的新的药代动力学和微生物学预测方程。
Pharmaceuticals (Basel). 2022 Jan 20;15(2):122. doi: 10.3390/ph15020122.
7
Virtual Combinatorial Chemistry and Pharmacological Screening: A Short Guide to Drug Design.虚拟组合化学与药理学筛选:药物设计简明指南。
Int J Mol Sci. 2022 Jan 30;23(3):1620. doi: 10.3390/ijms23031620.
8
Molecular Topology for the Search of New Anti-MRSA Compounds.寻找新型抗耐甲氧西林金黄色葡萄球菌化合物的分子拓扑学
Int J Mol Sci. 2021 May 29;22(11):5823. doi: 10.3390/ijms22115823.
使用 LDA 和决策树进行α-淀粉酶和α-葡萄糖苷酶抑制剂分类研究的模型可解释性之外。
Chem Biol Drug Des. 2019 Jul;94(1):1414-1421. doi: 10.1111/cbdd.13518. Epub 2019 May 16.
4
Novel multitarget-directed ligands targeting acetylcholinesterase and σ receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase.新型靶向乙酰胆碱酯酶和σ受体的多靶点配体作为治疗阿尔茨海默病的先导化合物:与乙酰胆碱酯酶形成复合物的合成、评价和结构特征。
Eur J Med Chem. 2019 Jan 15;162:234-248. doi: 10.1016/j.ejmech.2018.10.064. Epub 2018 Nov 8.
5
Application of Machine Learning Approaches for the Design and Study of Anticancer Drugs.机器学习方法在抗癌药物设计与研究中的应用。
Curr Drug Targets. 2019;20(5):488-500. doi: 10.2174/1389450119666180809122244.
6
In Silico SAR Studies of HIV-1 Inhibitors.HIV-1抑制剂的计算机辅助构效关系研究
Pharmaceuticals (Basel). 2018 Jul 13;11(3):69. doi: 10.3390/ph11030069.
7
Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review.基于机器学习的虚拟筛选及其在阿尔茨海默病药物发现中的应用:综述。
Curr Pharm Des. 2018;24(28):3347-3358. doi: 10.2174/1381612824666180607124038.
8
The rise of deep learning in drug discovery.深度学习在药物发现中的崛起。
Drug Discov Today. 2018 Jun;23(6):1241-1250. doi: 10.1016/j.drudis.2018.01.039. Epub 2018 Jan 31.
9
Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.多种谷氨酸衍生物和类似物作为基质金属蛋白酶-2 抑制剂的分子建模研究。
SAR QSAR Environ Res. 2018 Jan;29(1):43-68. doi: 10.1080/1062936X.2017.1406986. Epub 2017 Dec 19.
10
Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus.针对耐甲氧西林金黄色葡萄球菌的新型活性药物搜索的拓扑模式。
Eur J Med Chem. 2017 Sep 29;138:807-815. doi: 10.1016/j.ejmech.2017.07.010. Epub 2017 Jul 8.